High prevalence of occult papillary thyroid carcinoma in a surgical series for benign thyroid disease
…, D Casara, A Fassina, B Busnardo - Tumori …, 1990 - journals.sagepub.com
Nel presente studio vengono riportati i dati relativi alla elevata prevalenza (10.5%) di carcinoma
papillare occulto riscontrata per mezzo di un'accurata indagine istologica in un gruppo …
papillare occulto riscontrata per mezzo di un'accurata indagine istologica in un gruppo …
[PDF][PDF] Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables
…, A Favero, ME Girelli, B Busnardo - Journal of Nuclear …, 1993 - Soc Nuclear Med
… Benedetto Busnardo … Casara D, Zorat PL, Busnardo B, GIreIIiME. Pulmonaly
metastases from differentiatedthyroidcarcinomadetectedonly by radionuclideimaging.Br …
metastases from differentiatedthyroidcarcinomadetectedonly by radionuclideimaging.Br …
Treatment of solitary autonomous thyroid nodules by percutaneous ethanol injection: results of an Italian multicenter study. The Multicenter Study Group
…, P Bellitti, E Papini, B Busnardo… - The Journal of …, 1996 - academic.oup.com
Percutaneous intranodular ethanol injection (PEI) has been proposed for the therapy of
autonomously functioning thyroid nodules. In 1992, an Italian multicenter study was undertaken …
autonomously functioning thyroid nodules. In 1992, an Italian multicenter study was undertaken …
Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake
…, F Mantero, G Opocher, B Busnardo… - Clinical …, 2008 - Wiley Online Library
Objective Papillary thyroid cancers (PTCs) with no iodine uptake have an aggressive
behaviour and a poor prognosis. The aim of our study was to characterize, at molecular level, a …
behaviour and a poor prognosis. The aim of our study was to characterize, at molecular level, a …
[PDF][PDF] Clinical meaning of circulating anti-thyroglobulin antibodies in differentiated thyroid cancer: a prospective study
…, ME Girelli, M Piccolo, B Busnardo - Journal of Nuclear …, 1992 - Soc Nuclear Med
RESULTS For the 43 DTC patients, TgAb levels before therapy and at last control, after a
mean 3.55 yr follow-up period, are shown in Figure 1. Pre-therapeutic values of circulating …
mean 3.55 yr follow-up period, are shown in Figure 1. Pre-therapeutic values of circulating …
Life events in the pathogenesis of Graves' disease. A controlled study
…, M Boscaro, F Fallo, B Busnardo… - European Journal of …, 1993 - academic.oup.com
Contradictory findings have been reported about a possible causal relationship of life stress
to Graves' disease. We evaluated this issue by investigating the occurrence of stressful life …
to Graves' disease. We evaluated this issue by investigating the occurrence of stressful life …
Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow‐up of medullary thyroid carcinoma
B Busnardo, ME Girelli, N Simioni, D Nacamulli… - Cancer, 1984 - Wiley Online Library
Serum levels of calcitonin (CT) and carcinoembryonic antigen (CEA) were evaluated in a
group of 41 patients with histologically proven medullary thyroid carcinoma (MCT) before and …
group of 41 patients with histologically proven medullary thyroid carcinoma (MCT) before and …
The extent of surgery for thyroid medullary cancer
…, A Piotto, A Toniato, ME Girelli, B Busnardo… - Tumori …, 1994 - journals.sagepub.com
Al fine di valutare l'impatto dell'estensione dell'intervento chirurgico sulla prognosi del
carcinoma midollare della tiroide (CMT) sono stati analizzati retrospettivamente 72 pazienti …
carcinoma midollare della tiroide (CMT) sono stati analizzati retrospettivamente 72 pazienti …
Natural course of subclinical hypothyroidism in Down's syndrome: prospective study results and therapeutic considerations
…, M Piccolo, C Betterle, B Busnardo - Journal of …, 1995 - Springer
Pathogenesis, natural course and therapeutic management of subclinical hypothyroidism (SH)
in Down’s syndrome (DS) remain object of debate in literature. In the present study …
in Down’s syndrome (DS) remain object of debate in literature. In the present study …
BRAF in primary and recurrent papillary thyroid cancers: the relationship with 131I and 2-[18F]fluoro-2-deoxy-d-glucose uptake ability
…, D Nacamulli, ME Girelli, B Busnardo… - European Journal of …, 2010 - academic.oup.com
Objective BRAF V600E is a potential marker of poor prognosis in papillary thyroid cancers (PTC).
In a previous report, we showed that recurrent PTC with no radioiodine ( 131 I) uptake …
In a previous report, we showed that recurrent PTC with no radioiodine ( 131 I) uptake …